ARCHIVES

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays Recompetition of Drug Discovery Groups

October 22, 1993

NCI Encourages New Regional Cooperative Groups

November 19, 1976

NCI Separates Carcinogenesis Research Efforts

February 18, 1977

In Brief: Carbone To Leave NCI for Wisconsin ACS’ Holleb Says Tobacco Industry Tries to Hide Ad Warning

October 3, 1975

In Brief: Henney Names Acting Director Of DRCCA: House Bill Would Slash Deeply Into Research Using Animals

September 11, 1981

Attacks On Cancer, Program Peak Following Post Series; Defenders Cite Inaccuracies, Misconceptions

November 6, 1981